Connection

Thomas Keane to Urinary Bladder Neoplasms

Back to Details
This is a "connection" page, showing publications Thomas Keane has written about Urinary Bladder Neoplasms.
Thomas Keane
Connection Strength
1.168
Urinary Bladder Neoplasms
  1. Bladder cancer--resection/ablation. Surg Oncol Clin N Am. 2005 Apr; 14(2):321-52.
    View in: PubMed
    Score: 0.221
  2. Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model system. J Urol. 1998 Jul; 160(1):252-6.
    View in: PubMed
    Score: 0.138
  3. Methoxypsoralen phototherapy of transitional cell carcinoma. Urology. 1994 Dec; 44(6):842-6.
    View in: PubMed
    Score: 0.108
  4. A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer. Am J Clin Oncol. 2014 Apr; 37(2):188-93.
    View in: PubMed
    Score: 0.103
  5. Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model. Cancer Res. 1994 Jan 15; 54(2):475-81.
    View in: PubMed
    Score: 0.101
  6. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. J Urol. 1991 Nov; 146(5):1418-24.
    View in: PubMed
    Score: 0.087
  7. Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. J Urol. 1990 Oct; 144(4):1004-9.
    View in: PubMed
    Score: 0.081
  8. Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection. Int J Cancer. 2008 Sep 15; 123(6):1357-63.
    View in: PubMed
    Score: 0.070
  9. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol. 2006 Jun; 175(6):2312-6.
    View in: PubMed
    Score: 0.060
  10. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005 Dec; 96(9):1280-5.
    View in: PubMed
    Score: 0.058
  11. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol. 2000 Dec; 13(12):1315-23.
    View in: PubMed
    Score: 0.041
  12. pT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol. 2000 Jan; 7(1):13-25.
    View in: PubMed
    Score: 0.038
  13. Two cases of vasculitis of the urinary bladder: diagnostic and pathogenetic considerations. Arch Pathol Lab Med. 1998 Oct; 122(10):903-6.
    View in: PubMed
    Score: 0.035
  14. Intravesical suramin in the prevention of transitional cell carcinoma. Urology. 1995 Jan; 45(1):59-63.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.